Sphere Fluidics

Sphere Fluidics was spun out from the University of Cambridge in 2010 to commercialise novel technology based on the microfluidic handling of picolitre-scale droplets (picodroplets), which can be used to separate and encapsulate single cells for downstream analysis.

This technology is incorporated into an ultra-high-throughput single cell sorting and analysis instrument called the Cyto-Mine®, which was released in 2017 for use in biopharmaceutical discovery—a market currently worth £315m per annum and experiencing annual growth of 10%.

Visit website